Evidence map›Paper›PMID 30410380›Full record

ArticleClinical, cosmetic and investigational dermatology2018

Potential protective effects of rhEGF against ultraviolet A irradiation-induced damages on human fibroblasts.

Ji Min Kim, Jung Eun Choo, Ki Nam Kim, Yang Seok Kim

Open access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ji Min KimLife Science Research Institute, Daewoong Pharmaceutical Co.,Ltd., Yongin, Korea.
Jung Eun ChooLife Science Research Institute, Daewoong Pharmaceutical Co.,Ltd., Yongin, Korea.
Ki Nam KimLife Science Research Institute, Daewoong Pharmaceutical Co.,Ltd., Yongin, Korea.
Yang Seok KimDepartment of Science in Korean Medicine, Kyng Hee University, Seoul, Korea, yskim1158@khu.ac.kr.
Daewoong Pharmaceutical (South Korea) · KRKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUltraviolet A (UVA) rays reach the dermal skin layer and generate oxidative stress, DNA damage, and cell inflammation, which in turn lead to photo-aging and photo-carcinogenesis. While there have been many studies about the beneficial effects of topical epidermal growth factor (EGF) treatment in the healing of wounds, the effect of EGF on UVA-induced skin irritation remains unknown. To clarify the effects of EGF on UVA-induced skin damage, it was investigated whether EGF signaling can affect intracellular reactive oxygen species (ROS) and DNA damages in UVA-irradiated human dermal fibroblasts. MATERIALS AND

methodsFibroblasts cultured with or without rhEGF were UVA-irradiated at 40 mJ/cm

resultsAs a result, it was revealed that recombinant human EGF (rhEGF) inhibited UVA- increased intracellular ROS in the fibroblasts and increased the expression of catalase and SOD-1. Moreover, in UVA-irradiated fibroblasts, the longest DNA-damaged tails were observed, but this phenomenon was not detected in cells cotreated with both UVA and rhEGF. Also, it was observed that DNA damage induction, including that of cyclobutene pyrimidine dimers, pyrimidine (6-4) pyrimidone photoproducts, and 8-hydroxy-2-deoxyguanosine, was caused by UVA irradiation. Similar to previous results, it was downregulated by rhEGF. Furthermore, rhEGF also inhibited NF-κB gene expression and the NF-κB p65 protein level in the nucleus induced by UVA irradiation.

conclusionThese results suggest that EGF might be a useful material for preventing or improving photo-aging.

Indexed as

8-hydroxy-2 -deoxyguanosinecatalasecyclobutane pyrimidine dimersepidermal growth factorpyrimidine (6-4) pyrimidone photoproductssuperoxide dismutase-1UVA

Identifiers

PMID30410380
PMCPMC6199234
OpenAlexW2896946723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.